The Trypanosoma cruzi ascorbate peroxidase is, by sequence analysis, a hybrid type A member of class I heme peroxidases [TcAPx-cytochrome c peroxidase (CcP)], suggesting both ascorbate (Asc) and cytochrome c (Cc) peroxidase activity. Here, we show that the enzyme reacts fast with H 2 O 2 (k = 2.9 × 10 7 M
The Trypanosoma cruzi ascorbate peroxidase is, by sequence analysis, a hybrid type A member of class I heme peroxidases [TcAPx-cytochrome c peroxidase (CcP)], suggesting both ascorbate (Asc) and cytochrome c (Cc) peroxidase activity. Here, we show that the enzyme reacts fast with H 2 O 2 (k = 2.9 × -derived radical was identified by electron paramagnetic resonance spin trapping, immunospin trapping, and MS analysis after equimolar H 2 O 2 addition, supporting an alternative electron transfer (ET) pathway from the heme. Molecular dynamics studies revealed that ET between Trp 233 and Cys 222 is possible and likely to participate in the catalytic cycle. Recognizing the ability of TcAPx-CcP to use alternative reducing substrates, we searched for its subcellular localization in the infective parasite stages (intracellular amastigotes and extracellular trypomastigotes). TcAPx-CcP was found closely associated with mitochondrial membranes and, most interestingly, with the outer leaflet of the plasma membrane, suggesting a role at the host-parasite interface. TcAPx-CcP overexpressers were significantly more infective to macrophages and cardiomyocytes, as well as in the mouse model of Chagas disease, supporting the involvement of TcAPx-CcP in pathogen virulence as part of the parasite antioxidant armamentarium.
Trypanosoma cruzi | heme peroxidase | oxidants | virulence | kinetics T he protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disease (CD; also known as American trypanosomiasis). Up to 10 million people across Latin America are infected with this protozoan parasite, a distribution range that is expanding driven by migration of infected insects and hosts, with CD now emerging as a public health problem at nonendemic sites (1, 2) . T. cruzi strains are heterogeneous, exhibiting a high degree of biochemical and genetic variability. Such differences are believed, at least in part, to be responsible for disease outcome, which ranges from being asymptomatic during the course of infection to fatal severe cardiac and digestive complications (3) . It has been shown that the parasite antioxidant systems are essential for parasite survival and establishment of the infection in the vertebrate host (4) (5) (6) (7) . In contrast to most eukaryotes, T. cruzi lacks catalase and selenium-dependent glutathione peroxidases, which are enzymes capable of rapidly metabolizing high levels of H 2 O 2 (8, 9) . Instead, it expresses an array of complex enzyme-mediated mechanisms in which the trypanosomatid-specific thiol trypanothione ([T(SH) 2 ], N 1 ,N 8 -bisglutathionylspermidine) plays a central role in the funneling of reducing equivalents to the different peroxidase antioxidant systems (10) . Two typical 2-Cys peroxiredoxins are located in the cytosol (CPX) and in the mitochondrial matrix (MPX), respectively, and efficiently scavenge H 2 O 2 , peroxynitrite, and smallchain organic hydroperoxides (11) (12) (13) . Two glutathione-dependent peroxidases are located at the endoplasmic reticulum (ER) and in the cytosol, and seem to be important in the metabolization of lipidderived hydroperoxides (14) . Finally, a plant-like related heme peroxidase located at the ER displays ascorbate (Asc)-dependent peroxidase activity (APx) (15) .
Because the T. cruzi antioxidant defense systems are distinct from its mammalian host, the trypanosomal activities are suitable targets for specific rationale pharmacological inhibition. During its life cycle, T. cruzi undergoes various morphological and biochemical changes. One of the most complex transformations occurs during
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Trypanosoma cruzi, the causative agent of Chagas disease, affects 8-10 million people in Latin America. Parasite antioxidant systems are essential for parasite survival and infectivity in the vertebrate host. Herein, we characterized the enzymic properties, subcellular localization, and contribution to parasite virulence of a T. cruzi hybrid type A member of class I heme peroxidases. The enzyme reacts fast with hydrogen peroxide and utilizes both ferrocytochrome c and ascorbate as reducing substrates [T. cruzi ascorbate peroxidase (TcAPx)-cytochrome c peroxidase (CcP)]. A unique subcellular distribution of TcAPx-CcP in the infective stages suggests a role during parasite-host interactions. Infection of macrophages and cardiomyocytes, as well as in mice, confirmed the involvement of TcAPx-CcP in pathogen virulence as part of the parasite antioxidant armamentarium. metacyclogenesis, the process where a noninfective and replicative insect-derived epimastigote cell transforms to a highly infectious, nonreplicative, metacyclic trypomastigote. During this process, it has been shown that T. cruzi up-regulates several antioxidant enzymes to preadapt to the hostile environment of the vertebrate host (5, 16, 17) . Enzymes known to be up-regulated during this differentiation process include peroxiredoxins, [T(SH) 2 ] synthase (5), Fecontaining superoxide dismutases, and APx (16) .
T. cruzi ascorbate peroxidase (TcAPx) was first reported to reduce H 2 O 2 catalytically in the presence of Asc as the reducing substrate (APx activity), but with a catalytic efficiency several fold lower than plant APx (18, 19) . Its overexpression confers parasite resistance toward exogenously added H 2 O 2 toxicity (13, 15, 20) . Recent studies have shown that T. cruzi lacking TcAPx is still capable of infecting cultured mammalian cells, albeit at a reduced level, and can still establish an infection in the mouse model of CD (20) . Although the enzyme does not seem to be essential for parasite infectivity, its enhanced expression may represent an additional skill for the parasite to deal with host-derived oxidant toxicity both in the acute and chronic stages of the disease (6, 21) .
TcAPx shares significant homology (62% identity and 86% similarity) with its Leishmania major peroxidase (LmP) counterpart (18) . Both parasite enzymes are related to the class I heme-peroxidase group of antioxidant enzymes that includes catalase-peroxidase (katG), APx, cytochrome c peroxidase (CcP), and the hybrid type (A and B) peroxidases (22) . Phylogenetic studies have classified the T. cruzi and Leishmania enzymes as members of the hybrid type A, subfamily A1, heme peroxidases (23) , with other sequences in this group displaying both Asc-and cytochrome c (Cc)-dependent peroxidase activities (22, 24) . Based on this fact, we have renamed TcAPx as TcAPx-CcP. These hybrid type A peroxidases represent a real turning point in the evolution of ancient bifunctional catalase-peroxidase toward monofunctional specialization within this family, and their biochemical characterization may help to unravel the evolution of structurefunction relationships of these abundant oxidoreductases (23) .
LmP can use both Asc (as monofunctional APx) and Cc (as monofunctional CcP) as electron donors (25) . , compound I-like). Finally, using either Asc or Cc as the reducing substrate, the enzyme recovers the resting state (Fe-III-P). Classical compound I formation in these hybrid type A peroxidases was established by direct electron paramagnetic resonance (EPR) analysis (25) and/or by spectroscopic studies using a W208F mutant (25, 26) . To date, LmP represents the only trypanosomatid hybrid type A peroxidase characterized as using Asc and Cc as electron donors, with its activity implicated in parasite differentiation and oxidative stress protection (27) . Biochemical characterization of other members of this family of peroxidases may help to unravel the catalytic mechanism of these ancient enzymes as well as to define their role in pathogen survival, proliferation, and virulence.
In the present work, we characterized the Cc-dependent peroxidase activity of TcAPx-CcP. After a fast reaction with H 2 O 2 , an intramolecular electron transfer (ET) pathway at the heme microenvironment necessary for the oxidation of Cc was revealed; indeed, in addition to Trp, the role of a Cys residue typically located in the active site of these hybrid type A peroxidases was disentangled. Also, in light of its CcP activity and the presence of a secretory motif, which predicts membrane localization in all other hybrid type A members studied (15, 22, 23) , we explored the subcellular localization of the enzyme in the infective T. cruzi parasite stages. Finally, the role of TcAPx-CcP overexpression in parasite virulence was assessed through in vitro and in vivo infections in the cellular and acute murine model of CD.
Results
Visible Spectral Studies of TcAPx-CcP Reaction with H 2 O 2 . Recombinant T. cruzi wild-type (wt) and W233F APx-CcP were purified to homogeneity (>99% pure) by affinity chromatography as assayed by SDS/PAGE (Fig. 1A and Fig. S1A ). For all purifications ca. 70% of protein had Fe incorporated (as determined by the Soret peak absorbance in relation to the total protein content). To investigate the reaction of TcAPx-CcP with H 2 O 2 , the optical spectra of TcAPx-CcP (from 350 to 650 nm) were recorded before and after the addition of equimolar concentrations of H 2 O 2 to assay the spectral shifts associated with the formation of a compound I-like product (Fig. 1B) . The resting enzyme exhibited a Soret peak at 409 nm that shifted to 420 nm after reaction with H 2 O 2 , with the appearance of two humps at 539 and 560 nm. These changes in the optical spectra are indicative of the generation of a compound I-like product (25, 26, 28) (Fig. 1B) . When the W233F mutant was analyzed, the Soret peak was found to be at 414 nm in the resting state, indicating some structural perturbation at the heme microenvironment due to the amino acid replacement (Fig.  1C) . Upon reaction with H 2 O 2 , the Soret peak shifted to 418 nm, with only the 560-nm hump now present (Fig. 1C) . Given the rapid generation of the compound I-like product, rapid kinetics analysis by stopped flow at 10°C was performed to visualize the classical compound I in TcAPx-CcP. The maximal absorption (Soret peak) in the ferric state of heme peroxidases drops in intensity when the enzyme reacts with H 2 O 2 to form compound I, so a decrease in absorbance at the Soret peak is expected after H 2 O 2 reaction (26, 28, 29) . A very fast decay in absorbance for the wt enzyme (Soret peak at 409 nm) was observed upon mixing with H 2 O 2 , indicating the formation of the Fe-
•+ radical of compound I (Fig.  1D) . Interestingly, data in Fig. 1E , show that in the T. cruzi W233F mutant, a very fast (5 ms) and minor decay in absorbance at the Soret peak (414 nm) was followed by a slower increase in absorbance, suggesting the generation of an "alternative compound I-like" species. The drop in absorbance at 414 nm for the W233F mutant is in agreement with the spectral data shift upon H 2 O 2 addition shown in Fig. 1C . Because the compound I was not stabilized Fig. 2A) . In this mutant, a 10-fold decrease in Asc-dependent activity was also measured. To characterize the Cc-dependent peroxidase activity further, steady-state kinetic analysis was performed in the presence of wt TcAPx-CcP (0.05 μM), and . To determine the rate constant of the enzyme with H 2 O 2 , the absorbance at 390 nm (a λ value at which the resting and oxidized enzyme have significant absorbance differences; Fig. 1B ) was followed by rapid stopped-flow techniques. The reaction of H 2 O 2 (8 μM) with TcAPx-CcP (2 μM) led to a fast time-dependent decrease in absorbance (Fig.  2E) . The time course was fitted to a double exponential decay, with observed rate constants for both phases dependent on H 2 O 2 concentration (Fig. 2F) . The slopes of the plot (Fig. 2F) (33) . Thus, the slower process is likely to represent (because no reducing substrate was present) the reaction of a second molecule of H 2 O 2 with the oxidized TcAPx-CcP species, leading to an inactive form of the enzyme. Indeed, under these experimental conditions, we also observed a time-dependent inactivation of the enzyme by H 2 O 2 (SI Materials and Methods and Fig. S1 ). In Table 1 , the parameters of the steady-state kinetic analysis at pH 7.4 of TcAPx-CcP when using Cc (Fig. 2) or Asc (Fig. S2 ) as the reducing substrates are shown. Overall, the efficiency of TcAPx-CcP when using Cc is one order of magnitude higher than with Asc. . To determine the amino acid-derived radicals participating in the TcAPx-CcP catalytic cycle after reaction with H 2 O 2 , EPR spin trapping studies were carried out. Upon addition of equimolar concentrations of H 2 O 2 to the wt enzyme (60 μM) in the presence of the spin trap 3,5-dibromo-4-nitroso benzene sulfonate (DBNBS) (10 mM), an immobilized carbon-centered radical adduct signal that has a nitrogen hyperfine splitting constant (a N ) value of 32 G (or 2a N = 64 G); this signal was absent in the W233F mutant (Fig. 3) . Overall, these results strongly support the participation of a Trp 233 -derived radical in the generation of the compound I-like product. Detailed inspection of the heme microenvironment in hybrid type A and CcP peroxidases revealed the presence of a Cys residue (Cys 222 for T. cruzi enzyme) located near Trp 233 (25, 34) ; this Cys residue is absent in the APx family (23) . It has been proposed that the sulfur atom of this Cys residue favors stabilization of the LmP compound I-like product. Indeed, mutation of Cys 197 to Thr in LmP decreased more than 100-fold the Cc 2+ -dependent peroxidase activity without affecting the Asc-dependent function (25, 26) . We thus explored the involvement of Cys 222 in TcAPx-CcP peroxidase activity by means of alkylation of enzyme thiols with N-ethyl-maleimide (NEM). Of the six Cys residues present in TcAPx-CcP, two are buried in the protein structure and four (including Cys 222 ) are solvent-accessible. As shown in Fig. 4 , NEM-treated wt enzyme reacts with H 2 O 2 (as wt nontreated enzyme) with the generation of a compound I-like product (Fig. 4A ). Although the NEMtreated enzyme reacted with H 2 O 2 , Cc 2+ -dependent peroxidase activity was decreased by more than 70% compared with wt enzyme, although the Asc-dependent peroxidase activity was not affected (25, 26) (Fig. 4D) . Interestingly, when the NEM-treated W233F mutant was exposed to H 2 O 2 , no changes in the Soret peak at 414 nm of the resting Fe-III was observed (Fig. 4C) . In this condition, a significant drop in Asc-dependent peroxidase activity was also evident for the W233F-NEM enzyme (Fig. 4D) . Overall, the above results indicate that Cys 222 (located near the heme and Trp 233 ) is necessary for compound I-like generation/ stability.
To determine the generation of a Cys 222 radical accurately after reaction of TcAPx-CcP with H 2 O 2 , immunospin trapping assays using 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) were performed. Untreated or NEM-treated wt and W233F enzymes (10 μM) were exposed to H 2 O 2 (0-30 μM) in the presence of DMPO (100 mM). DMPO-protein adducts were evaluated by Western blot using the anti-DMPO-nitrone antibody as previously reported (35) . In the wt enzyme, DMPO-nitrone adducts were observed with a signal intensity dependent on H 2 O 2 concentration (Fig. 5A ). These immunoreactive signals were completely abrogated in the NEM-treated enzyme, strongly suggesting the participation of Cys in the detected protein adduct (Fig. 5A) . Moreover, the signal was greatly enhanced in the W233F mutant, suggesting that in the absence of Trp 233 , Cys 222 could be involved in the recovery of compound I, leading to an alternative ET pathway, as suggested from data in Fig. 1D . These results were corroborated by EPR spin trapping analysis (Fig. 5B) . Reaction of the wt enzyme (60 μM) with equimolar concentrations of H 2 O 2 in the presence of DMPO (100 mM) yielded a detectable paramagnetic signal; notably, the EPR signal was significantly enhanced in the W233F mutant (Fig. 5B, line B) . One hyperfine splitting constant of the beta hydrogen (a H β ) of the adduct signal (a H β = 16 G) is fully consistent with the trapping of an APx-CcPcysteinyl radical, whereas another (a H β = 9.3 G) suggests that a Tyr radical may be also trapped (36, 37) . Furthermore, the formation of the DMPO radical adduct was almost fully inhibited in the NEMtreated wt and W233F enzymes (Fig. 5B, lines C) . The results indicate the generation of a protein-derived radical located at the active site Cys 222 (alternative compound I-like) that is important for the TcAPx-CcP Cc-dependent peroxidase activity ( . Using the previously reported crystallographic structure of LmP [Protein Data Bank (PDB) ID code 3RIV], we performed homology models for the TcAPx-CcP (25) (Fig. S3) , from which 100-ns-long molecular dynamics (MD) simulations were conducted. The proximal site of the heme in , but also with the heme porphyrin aromatic system mainly in the form of thiolate (Fig. 6 and Fig. S4A ). To understand the redox interplay at the heme microenvironment involving the heme, Trp
233
, and Cys 222 better, we performed ET probability calculations by using the "pathways" formalism. By means of this method, the possible paths for ET from Trp 233 and Cys 222 to the oxoferryl heme were computed throughout the MD trajectories. The best possible structural path (i.e., the higher electronic coupling matrix) connecting the electron donor and acceptor was obtained, allowing us to analyze and compare key structural features governing the ET process. In Fig. S4B , the average values are shown. The data support that the preferred ET pathway involved the heme-dependent oxidation of Trp 233 (Fig. 7, route A) 222 to yield the corresponding cysteinyl radical and establishing a redox equilibrium between the two amino acid-derived radical species. On the other hand, in the W233F mutant, the oxidized heme will promote the direct one-electron oxidation of the thiolate form of Cys 222 (Fig. 7, route B) , thus maintaining the Asc peroxidase activity of the enzyme in the absence of Trp 233 (Fig. 4D ).
Subcellular Localization of TcAPx-CcP in the Infective Parasite Stages.
Here, the kinetic data shown above indicate that the TcAPxCcP-preferred source of reducing equivalents is Cc. In addition to the previously reported ER localization in the noninfective epimastigote stage (15), we searched for the presence of TcAPxCcP in the mitochondrial compartment (where Cc is present) in the different parasite stages (noninfective epimastigotes, infective intracellular amastigotes, and extracellular trypomastigotes) using specific antibodies (Fig. S5) . First, and using TcAPx-CcP overexpressers (epimastigote), we conducted controlled-digitonin permeabilization studies to evaluate the coelution of the enzyme with mitochondrial markers (Fig. S6A) . TcAPx-CcP was found to coelute with Cc and Fe-superoxide dismutase A (SODA) (mitochondrial markers), and it was also present in the membrane fraction (Fig. S6A ). This result indicates that at least a fraction of the enzyme is associated with mitochondria. Immunofluorescence microscopy of T. cruzi epimastigotes evidences a nonhomogeneous distribution of the enzyme, compatible with ER localization (15) . The enzyme is also present in close proximity to mitochondrial DNA and Fe-SODA (Fig. S6B) . Finally, to localize proteins at the ultrastructural level precisely, providing simultaneous visualization of antigen epitopes together with the ultrastructure of membrane compartments, we conducted immunoelectron microscopy (immuno-EM) (38) of TcAPx-CcP in the infective T. cruzi stages. TcAPx-CcP enzyme was found to be located in mitochondria, particularly associated with membranes of the cristae (Fig. 8B and Figs. S7 and S8).
The localization of TcAPx-CcP in mitochondria was different from the localization observed for MPX located at the mitochondrial matrix (11) (Fig. 8 C-E) . Intriguingly, the enzyme was found to be associated with the plasma membrane of the intracellular amastigote and extracellular trypomastigote stages, potentially forming a "shield" at the host-parasite interface ( overexpressers using the monoclonal anti-c-Myc antibody in both the trypomastigote and amastigote stages (Fig. S7) . The presence of TcAPx-CcP at the host-parasite interface strongly suggests its participation in the parasite defense mechanisms toward host-derived toxicity. To date, the physiological reducing substrate (i.e., Asc, Cc, or both) for this ancient enzyme in T. cruzi is still elusive (Discussion).
Enhanced Virulence of TcAPx-CcP Overexpressers in Cellular and Mice
Infections. T. cruzi interaction with macrophages leads to the assembly of the membrane-bound NADPH oxidase with the generation of sustained (90 min) and large amounts of superoxide radical, and thus hydrogen peroxide, directed toward the internalized parasite (7). Once internalized, T. cruzi has to deal with the oxidative environment of the phagosome to survive and escape to the host cytosol, where it proliferates as amastigotes. Thus, we first searched for parasite survival in naive macrophage infections. Macrophages were infected with wt or TcAPx-CcPoverexpressing trypomastigotes, and infection yields were evaluated after 24 h by intracellular amastigote counting. Trypomastigotes overexpressing TcAPx-CcP were more resistant to macrophage toxicity compared with wt parasites, indicating the participation of TcAPx-CcP in the H 2 O 2 detoxification generated during parasite internalization (Fig. 9A) . Finally, the infectivity of TcAPx-CcP overexpressers was evaluated in cardiomyocytes, cells where amastigotes can reside during chronic infection. It has been shown that T. cruzi cardiomyocyte infection leads to the establishment of host-mitochondrial dysfunction, with an increase in H 2 O 2 and inflammatory cytokine (IL-1β and TNF-α) production (39) . We evaluated the infectivity of TcAPx-CcP overexpressers following 96 h of infection, an incubation time sufficient to cause mitochondrial dysfunction in cardiomyocytes and to achieve amastigote replication in the host cell cytoplasm. Rat-derived ventricular cardiomyocytes (H9c2) were infected as above and incubated for 96 h. As was observed for macrophages, TcAPx-CcP overexpressers were more infective than wt parasites, supporting the participation of the enzyme in enhancing virulence (Fig. 9A) . These results correlate well with in vitro studies where TcAPxCcP-null parasites infect myoblast cells at a reduced level (20) . Finally, and to validate the enhanced virulence of the TcAPx-CcP overexpressers in vivo, we conducted mouse (BALB/c susceptible and C57BL/6 resistance lineages; Fig. 9B ) infections with culturederived trypomastigotes from wt (CL-Brener) and TcAPx-CcP overexpressers. As shown in Fig. 9B , TcAPx-CcP overexpressers produced higher blood parasitemias in the acute infection model of CD, indicating the role of this enzyme in parasite virulence and consistent with its function as part of the pathogen defense against host-derived cytotoxic oxidants.
Discussion
By phylogenetic (23) and biochemical studies (this work), TcAPx-CcP is a hybrid type A peroxidase sharing both Asc-and Cc-dependent peroxidase activity. Although initially described to use Asc as a reducing substrate (15) , the catalytic efficiency with Cc is higher, suggesting that, in vivo, the enzyme may also function as a CcP, so long as a component of TcAPx-CcP is present where this "alternative" reducing equivalent is found, such as the mitochondrion. Spectral analysis during the reaction of the enzyme with H 2 O 2 showed the formation of a compound-I like (Fig. 1B) these enzymes (25) . The classical compound I was transiently detected following fast absorption spectra of the resting enzyme at the Soret peak (409 nm) after the H 2 O 2 reaction (Fig. 1D) . The participation in the reaction of the critical Trp 233 located in close proximity to the heme was supported by EPR-spin trapping experiments (Fig. 3) and by the site-directed enzyme mutant (W233F) in experiments that included the lack of detection of the EPR signal in parallel with a great drop in the Cc-dependent activity and a 10-fold decrease in Asc-dependent peroxidase activity (Figs. 2 and 4) . Rapid UV-visible scanning of the W233F enzyme (Soret peak at 414 nm) permitted detection of an alternative compound I-like species (Fig. 1 C and E) , indicating that another redox-active amino acid located in the heme microenvironment was able to participate rapidly in the one-electron reduction of the porphyrin cation radical present in classical compound I. Protist hybrid type A heme peroxidases contain a Cys residue located near the heme (Cys 222 and Cys 197 for T. cruzi and LmP, respectively) (22) . Immunospin trapping, EPR-spin trapping, and peptide mapping-mass spectrometry analysis using DMPO revealed the presence of a cysteinyl radical in wt TcAPx-CcP upon H 2 O 2 reaction that was enhanced in the W233F mutant (Fig. 5) . Enzyme thiol alkylation dramatically lowered the Cc-dependent peroxidase activity of TcAPx-CcP in line with the participation of this residue in enzyme activity. In this sense, MD simulations revealed that in fact, once the Trp 233•+ is formed to yield the alternative compound I, a subsequent ET can occur with the participation of Cys 222 . For this ET to occur, once the Trp 233•+ is formed, it must lose a proton to yield the neutral indolyl radical (NTrp 233• ) that, in turn, can abstract a hydrogen atom for the neutral HS-Cys 222 , generating a cysteinyl radical (Cys 222 -S • ) (Eq. 1 and Fig. 7) , establishing the following equilibrium:
It is important to note that the estimated one-electron redox potentials of the iron/oxo complex and the tryptophanyl and cysteinyl radicals are approximately: 1,156, 1,025 and 970 mV, respectively, at pH 7.4 (40, 41) , all of which are thermodynamically consistent with preferential route "A" of the ET shown in Fig. 7 . In light of these data, we propose that the equilibrium involving the presence of Cys 222 (Eq. 1) allows the stabilization of the protein-derived radicals, permitting a more selective reactivity of Trp 233•+ toward Cc 2+ after binding of the reducing substrate to the active site. Overall, these observations indicate distinctive characteristics of the LmP enzyme compared with the T. cruzi enzyme (e.g., formation of compound-like I in Tc-APxCcP) and provide a detailed atomistic picture of the redox processes occurring at the heme microenvironment during catalysis in this family of peroxidases. Future studies involving crystallization of TcAPx-CcP and comparative analysis with LmP should help to rationalize the subtle differences observed herein in the reaction mechanism.
The hybrid type APx-CcP peroxidases have been proposed to represent an evolutionary link between catalase-peroxidase and Cc-peroxidases, although their physiological roles are still under discussion (23) . LmP, located at the parasite mitochondria, is involved in H 2 O 2 detoxification during parasite differentiation and infectivity (27, 42) . In light of its CcP activity, we searched for TcAPx-CcP localization in the different T. cruzi parasite stages. In addition to the early report of ER localization in the noninfective epimastigote stage, immuno-EM experiments revealed that the enzyme was also associated with the mitochondria cristae in all parasite stages (Fig. 8 and Fig. S7 ), suggesting that the mitochondrial-associated fraction of the enzyme may truly work as a CcP. In the intracellular amastigotes and extracellular trypomastigotes, TcAPx-CcP was also found to be noticeably located at the plasma membrane of the parasite in close interaction with the host cytosol, creating an "antioxidant shield" at the host-parasite interface (Fig. 8) . This membrane localization was not evident in the T. cruzi epimastigote stage (Fig. S7) . In this subcellular localization, TcAPx-CcP may principally use host cellderived Asc as a reductant to protect the parasite from H 2 O 2 . Overall, we speculate that the infective stage of the parasite uses the reducing substrates alternatively depending on their availability. Although micromolar Asc is found in both the host cytoplasm (43) and T. cruzi trypomastigotes (17) , micromolar Cc is also present in the mitochondrial intermembrane space (44) , supporting that TcAPx-CcP primarily uses Asc in its plasma membrane localization and Cc in the mitochondria ( Table 1) .
The cysteine-protease cruzipain is an example of enzyme subcellular relocalization along the T. cruzi life cycle, where restriction to vesicles of the endosomal/lysosomal system in the epimastigote stage is relocalized to the parasite surface in the intracellular amastigote stage (45) . The C-terminal extension in cruzipain was suggested to participate in this relocalization (46) . TcAPx-CcP contains a positively charged 17-aa sequence of unknown function close to the carboxyl terminus (15) that could be involved in such enzyme relocalization.
To evaluate the significance of TcAPx-CcP in infectivity, studies using cultured cells and animals were performed. Two cellular models (macrophages and cardiomyocytes) were used for the in vitro infection studies. First, T. cruzi infection of naive macrophages leads to activation of the plasma membrane NADPH oxidase, yielding large amounts of superoxide radical, and subsequently H 2 O 2 (due to superoxide dismutase-catalyzed dismutation), toward the internalized parasite (7, 47) . Second, T. cruzi cardiomyocyte infection leads to the establishment of host-mitochondrial dysfunction with increased H 2 O 2 production (39) that can diffuse and reach the intracellular amastigote. In both cellular models, parasites overexpressing TcAPx-CcP were more infective than controls, thus supporting the hypothesis that this peroxidase plays a role in protecting T. cruzi from the cytotoxic effects of host cell-derived H 2 O 2 (Fig. 9A) . Recent proteomic data indicate that virulent T. cruzi strains express high levels of TcAPx-CcP, with this expression being further elevated in the infective stage (16, 48) . However, it has now been shown that although TcAPx-CcP-null parasites are more susceptible to oxidant killing in vitro, the peroxidase activity is not a determinant for establishment of an infection in the animal model of CD, and is thus not essential for parasite survival within the mammalian host (20) . As an ancient parasite, T. cruzi is well adapted to infect and persist in the mammalian host, developing redundant activities that have allowed it to succeed in hostile oxidative environments. Trypanosomes null for TcAPx-CcP contain other oxidantmetabolizing systems, including CPX, that are able to detoxify H 2 O 2 efficiently and make parasite infection possible. For comparative purposes, the reaction rate values of H 2 O 2 with TcAPxCcP are 2.9 × 10 7 M −1 ·s −1 (this work) and 3 × 10 7 M −1 ·s −1 for CPX (49) , supporting that both systems are, in principle, readily capable of eliminating cytotoxic levels of host cell-derived H 2 O 2 . Moreover, two other putative heme peroxidases are present in the parasite genome (TcCLB.507011.130 and TcCLB.511143.30), and the relevance of their expression under different biological conditions remains to be defined. Finally, and to assay the infectivity of TcAPx-CcP-overexpressing parasites, infection trials in two different mice lineages (BALB/c and C57BL/6) were conducted. Higher and significantly different parasitemias were observed in both mouse models of acute CD for the TcAPx-CcP overexpressers with respect to wt parasites, confirming its role in parasite virulence (Fig. 9B) .
Overall, the data presented herein provide conclusive biochemical evidence of the hybrid nature of the type A heme peroxidase in T. cruzi (TcAPx-CcP); unravel mechanistic aspects of its redox enzymology with an atomic level of detail; and contribute to define its biological function, particularly its role as a virulence factor in CD.
Materials and Methods
Expression, Purification, and Site-Directed Mutagenesis of Recombinant TcAPxCcP. The plasmid for heterologous expression of TcAPx-CcP (pTrcHis-APX) was kindly provided by Shane Wilkinson, Queen Mary University, London (15) . Purification of recombinant enzymes was performed as done previously with minor modifications, as noted in SI Materials and Methods (15) . Purity of TcAPx-CcP preparations was evaluated by 15% SDS/PAGE (Fig. S1) , and the Soret peak at 409 nm for wt enzyme was used to quantitate the heme protein content (e = 101 mM −1 ·cm −1 ) (18). Site-directed mutagenesis of TcAPx-CcP (W233F) was performed using a site-directed mutagenesis kit with the following primers: forward, 5′-GGGCTACGTGGGTCCGTTCACG-CACGACAAG-3′, and reverse, 5′-CTTGTCGTGCGTGAACGGACCCACG-TAGCCC-3′. Sequence fidelity was confirmed by DNA sequencing (Institut Pasteur, Montevideo, Uruguay). The TcAPx-CcP W233F mutant was purified as described above for the wt enzyme, and the Soret peak at 414 nm was used to quantitate the heme protein content as described above. Protein concentration was measured by the Bradford protein assay.
Thiol Alkylation. Alkylation of wt and W233F TcAPx-CcP was carried out incubation of the enzyme (60 μM) with NEM (10 mM) for 2 h in phosphate buffer (100 mM, pH 7.4) at 4°C. Excess NEM was immediately removed using HiTrap desalting columns (Amersham Biosciences) in PBS (100 mM, pH 7.4). Thiol alkylation was confirmed by the 5,5′-dithiobis-2-nitrobenzoic acid assay (50) .
Spectroscopic Analysis. UV-visible spectra were recorded at 25°C from Ascfree wt and W233F enzymes (2 μM) in the presence or absence of an equimolar H 2 O 2 concentration in PBS (100 mM, pH 7.4).
Stopped-Flow Analysis. Rapid acquisition spectra and absorbance time courses were obtained following Asc-free wt and W233F enzymes before and after H 2 O 2 addition by mixing equal amounts (4 μM each) in sodium phosphate buffer (100 mM, pH 7.4) containing diethylenetriaminepentaacetic acid (DTPA) (0.1 mM) at 10°C, reaching a final concentration of 2 μM reagents.
Absorbance was recorded with an Applied Photophysics SX-20 stopped-flow spectrofluorometer (mixing time of ≤2 ms) equipped with a rapid-scanning diode array. Formation of compound I species was followed at a Soret peak of 409 nm for wt and 414 nm for W233F enzyme.
Steady-State Activity Assays and Rate Constant Determinations. The steadystate activity assays for wt TcAPx-CcP and W233F mutant were performed using Asc and Cc 2+ as reducing substrates, as previously described for LmP (25, 26) .
The Cc was prereduced with dithionite, and the excess reductant was removed immediately using HiTrap desalting columns in phosphate buffer (100 mM, pH 7.4). value was obtained from the V max value of substrate oxidation and considering the entire enzyme as the oxoheme complex intermediate,
A similar experimental approach was used for the determination of kinetic parameters for Asc (SI Materials and Methods and Fig. S2 ). For determination of the rate constant of the H 2 O 2 -dependent oxidation of TcAPx-CcP, the enzyme (2 μM) was rapidly mixed (using a stopped-flow spectrofluorometer) with H 2 O 2 (0-12 μM), and the change in absorbance at 390 nm due to enzyme oxidation was recorded. Data were fitted to biexponential curves. The observed rate constant values (k obs ) for the fast and slow processes were plotted as a function of H 2 O 2 concentration, and the second-order rate constants were determined from the slope of the plots.
EPR-Spin Trapping and Immunospin Trapping Studies of wt and W233F TcAPxCcP. EPR spectra of Asc-free TcAPx-CcP, W233F mutant, and NEM-treated enzymes were recorded at room temperature (25°C) on a MiniScope MS400 (Magnetech Instruments). For EPR experiments, the reaction mixture contained: wt or W233F (60 μM), DBNBS (10 mM) or DMPO (100 mM), H 2 O 2 (60 μM), and DTPA (0.1 mM) in phosphate buffer (100 mM, pH 7.4). Immediately after oxidant addition, samples were transferred to a 100-μL flat cell and the spectra recorded within 1 min (one-spectrum acquisition). Instrumental conditions were as follows: microwave power, 20 mW; modulation amplitude, 2.5 G; time constant, 0.2 s; and scan rate, 1.67 G/s. For immunospin trapping, wt, W233F (10 μM), and NEM-treated enzymes were exposed to H 2 O 2 (0-30 μM) in the presence of DMPO (100 mM). After treatment, proteins were subjected to SDS/PAGE, transferred to nitrocellulose membranes, and blocked in PBS (50 mM, pH 7.4) containing dry milk (5% wt/vol) for 1 h. Protein-DMPO adducts were detected using a chickenderived polyclonal anti-DMPO-nitrone primary antibody (kindly provided by Ronald Mason, National Institutes of Environmental Health Sciences, Research Triangle Park, NC) and rabbit polyclonal anti-TcAPx-CcP (1:2,000 dilution in PBS) containing Tween-20 (0.1% vol/vol) and BSA (4% vol/vol) as previously described (5). Membranes were washed and then probed for 1 h with anti-chicken IgG (IR Dye-800; Licor Bioscience) and anti-rabbit IgG (IR Dye-680; Licor Bioscience) in PBS containing Tween 20 (0.1% vol/vol). Immunoreactive proteins were visualized with an infrared fluorescence detection system (Odyssey; Licor Bioscience).
MD Simulations. MD simulations for wt and W233F mutant TcAPx-CcP were performed. Both initial structures were generated by homology modeling using the Swiss-Model package (51), using the structure of LmP solved at 1.76 Å resolution as a template, complexed with a heme prosthetic group and two cations: calcium and potassium (PDB ID code 3RIV). Both cations were kept in the systems, and the heme group was considered in the oxoferryl state.
A pK a prediction of ionizable protein residues was made with PROPKA (52) . Considering the PROPKA-computed values and examining the structures, protonation states were assigned for ionizable residues, promoting hydrogen bond formation. Because thiol/thiolate equilibrium may result critical in ET processes involving Cys residues, we also performed independent MD simulations for both protonation states of Cys
222
. The systems were placed into a truncated octahedral box of three point transferable intermolecular potential (TIP3P) water model and optimized with two steps of energy minimization, each consisting of 400 cycles with a force constant of 500 kcal·mol
plied over all atoms, excluding water molecules in the former and over backbone atoms only in the latter. Temperature was increased from 0 to 10 K with 10-ps constant-volume MD, a time step of 0.1 fs, and a harmonic restraint potential of 50 kcal·mol
·Å −2 applied over all protein residues, ions, and ferryl-oxoheme.
Thereafter, the temperature was raised from 10 to 300 K in 90-ps constant-volume MD with a 0.5-fs time step, applying a force constant of 10 kcal·mol
the protein backbone atoms, ions, and ferryl-oxoheme. After heating, density was equilibrated with 400-ps MD simulation at a constant temperature and pressure with a time step of 1 ps and applying a force constant of 1 kcal kcal·mol
·Å −2 to the protein backbone atoms, ions, and ferryl-oxoheme. A Langevin thermostat was used for temperature control, whereas a Berendsen barostat was chosen to adjust the pressure to 1 bar (both regulated every 1 ps). Then, 100-ns-long MD simulations within the NTP ensemble were carried out, with a time step of 2 fs. All of the simulations were performed under periodic boundary conditions (53) using the SHAKE algorithm (54) to keep hydrogen atoms at equilibria bond lengths, and long-range electrostatics interactions were handled with Ewald sums, setting a cutoff distance of 10 Å. Parameters used for ferryl-oxoheme were taken from a study by Capece et al. (55) .
ET Pathway Calculations. The probability of ET toward the ferryl-oxoheme group was calculated using the pathways algorithm (56, 57) . This method looks for the best possible path connecting the electron donor and the acceptor, and it was successfully used by our group previously (58) (59) (60) (61) (62) . Briefly, according to the Marcus theory (63), the ET rate constant (k ET ) depends on the reaction standard free energy (ΔG°), the reorganization energy (λ), and the electronic coupling matrix (T DA ), described in the following equation:
where Z is the Planck constant, k B is the Boltzmann constant, and T is the system temperature. The pathways method estimates the T DA for a given donor-acceptor couple, which is related to the probability of ET transfer, and thus directly involved in the resulting ET rate. Further details about parameters adjustments are provided by Ferreiro et al. (61) . To compute the T DA for each case, 400 representative snapshots from the last 80 ns of MD trajectories were used. All molecular visualization and drawings were performed with the Visual Molecular Dynamics program (64) .
Peptide Mapping-MS Analysis of DMPO-Adducts After Reaction with H 2 O 2 . Mutant W233F (16 μM) enzymes were treated with equimolar concentrations of H 2 O 2 in potassium phosphate buffer (100 mM, pH 7.4) at 25°C in the presence of DMPO (100 mM). Excessive DMPO was removed by buffer exchange with ammonium bicarbonate buffer (50 mM, pH 8) using HiTrap desalting columns and enzyme-digested (overnight at 37°C) with trypsin (trypsin/protein ratio of 20:1, sequencing grade; Promega). Tryptic digests were analyzed using a hybrid triple-quadruple linear ion trap mass spectrometer (QTRAP 4500; ABSciex) coupled online with a liquid chromatography system (Infinity 1260; Agilent). For the liquid chromatography-MS approach, peptides were separated on a reversed-phase column (Vydac 218TP; C18, 150 × 2.1 mm, 5 μm) and eluted with a linear gradient of acetonitrile (0.1% formic acid) from 0-45% in 90 min at a flow rate of 0.25 mL·min
. The electrospray voltage and declustering potential were set to 5.5 kV and 50 V, respectively, and the source temperature was 500°C. Initial scanning was performed in the Q1 positive ion mode with the unit resolution at 1,000 Da·s −1 using a mass range of 300-2,000 Da·s . Sequences from peptides of interest were performed by HPLC-tandem MS. Enhanced product ion analysis from selected peptide ions was performed using Q3 as a linear ion trap, with an optimized collision energy of 50 V and a mass range of 50-1,500 Da at 10,000 Da·s . Data were acquired using Analyst 1.6.2 software (ABSciex) and analyzed using the BioTool Kit designed for PeakView 2.1 (ABSciex).
Parasites. T. cruzi epimastigotes (CL-Brener, wt) were cultured at 28°C in brain heart infusion (BHI) containing heat-inactivated bovine fetal serum (10% vol/vol) as described previously (65) . T. cruzi epimastigotes overexpressing TcAPx-CcP were obtained as described previously (5, 15) . Transformed TcAPxCcP (CL-Brener-pTEX-APX-9E10) overexpressing epimastigotes were cultured in BHI medium as above containing G418 (250 μg/mL; Sigma).
Immuno-EM Studies. The specificity of the antibodies used for the immunolocalization studies was evaluated by Western blot of protein extracts (10 μg) from rat-derived cardiomyocytes (H9c2; American Type Culture Collection) and from the different parasite stages (amastigotes, trypomastigotes, and epimastigotes; Fig. S5 ). Cardiomyocytes were seeded in culture flasks (25 cm 2 ) and infected as above. After 48 h of infection, an equal volume of a freshly prepared mixture of 4% paraformaldehyde (PFA; % vol/vol) and 0.4% glutaraldehyde (GA; % vol/vol) in sodium phosphate buffer (0.1 M, pH 7.4) was added to the cultures to reach a final concentration of 2% PFA and 0.2% GA (% vol/vol). The cells were fixed for 30 min at room temperature, after which the fixative was refreshed and kept at 4°C. Samples were rinsed in sodium phosphate buffer (0.1 M, pH 7.4), and after overnight infiltration in sucrose (2.3 M), the cells were frozen in liquid nitrogen. Ultrathin cryosectioning and immunogold labeling were performed as described previously (66) . Sections were picked up with a drop of a 1:1 mixture of sucrose (2.3 M) and 1.8% (vol/vol) methyl-cellulose (25 centipoise; Fluka AG), thawed, and transferred to formvar carbon-coated copper grids. The sections were subsequently immunolabeled at room temperature by floating on drops containing the diluted antibody [anti-TcAPx-CcP, anti-MPX, and antimonoclonal c-Myc9E10 antibody (Santa Cruz Biotechnology) and 10 nm of protein A gold]. After incubation, the sections were washed in distilled water, stained for 5 min with uranyl-oxalate (pH 7.0), washed again, and embedded in a mixture of 1.8% (vol/vol) methyl cellulose and 0.3% uranyl acetate at 4°C. The sections were evaluated using a JEOL 1200CX electron microscope.
Cellular Infections. Parasites were differentiated to the infective metacyclic stage, and metacyclic forms were purified by overnight incubation with fresh human serum as previously described (5) . Metacyclic trypomastigotes were used to infect confluent Vero cells (American Type Culture Collection) at 37°C in a 5% CO 2 atmosphere. Culture-derived trypomastigotes were used to infect macrophages (J774A.1, ATCC-TIB-67; American Type Culture Collection) and cardiomyocytes (H9c2) cultured in DMEM (Sigma) supplemented with L-glutamine (2 mM), penicillin (100 units/mL), streptomycin (100 mg/mL), and heat-inactivated FBS (10% vol/vol) at 37°C in a 5% CO 2 atmosphere. Macrophages and/or cardiomyocytes were seeded in Lab-Tek chamber slides and infected with culture-derived trypomastigotes from wt and TcAPx-CcP overexpressers (parasite/cell ratio of 5:1) (7). Nonengulfed parasites were removed by washing twice in Dulbecco's PBS at pH 7.4 (Sigma), and cells were further incubated for 24-96 h in DMEM at 37°C. Infected cells were fixed in a 4% (vol/vol) fresh PFA solution in PBS for 10 min at room temperature, washed with PBS containing glycine (100 mM), and permeabilized for 5 min with 0.1% (vol/vol) Triton X-100 in PBS. The number of parasites per 100 macrophages and/or cardiomyocytes was determined by DAPI staining (5 μg/mL). Preparations were analyzed using a microscope (Nikon Eclipse TE-200) at a magnification of 1,000×, and digital photographs of infected cells were recorded. At least 2,500 cells from three independent experiments were counted. Results are expressed as the number of amastigotes per 100 cells and represent the mean of three independent experiments. Animal Infections. Male BALB/c or female C57BL/6 mice (7-10 wk old, respectively) were inoculated i.p. (five mice per group) with culture-derived trypomastigotes (1.5 × 10 7 trypomastigotes) from wt (CL-Brener strain) or TcAPx-CcP overexpressers. The different susceptibility of these murine models to acute T. cruzi infection was previously characterized (67) . Blood trypomastigote count (parasitemia) was assayed on blood (3 μL) drawn from the tail tips of mice, and the number of trypomastigotes per 32 fields was recorded from fresh blood in Neubauer chambers under a microscope (400× magnification).
Infection studies were approved by the Animal Ethics Committee (registration no. 070153-000119-5), registered with the Ethics Commission for the Use of Animals for Experimentation [Comisión de Ética en Uso de Animales (CEUA), Veterinary School, Uruguay], and mice were handled according to their guidelines.
